Je Jung Lee

Ontology type: schema:Person     

Person Info


Je Jung



Publications in SciGraph latest 50 shown

  • 2019-01 Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2017-12 Computational Modeling of complete HOXB13 protein for predicting the functional effect of SNPs and the associated role in hereditary prostate cancer in SCIENTIFIC REPORTS
  • 2017-09 The clonal origins of leukemic progression of myelodysplasia in LEUKEMIA
  • 2017-01 HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea in HEPATOLOGY INTERNATIONAL
  • 2016-12 Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen in BMC CANCER
  • 2016-09 Naïve CD8+ T cell derived tumor-specific cytotoxic effectors as a potential remedy for overcoming TGF-β immunosuppression in the tumor microenvironment in SCIENTIFIC REPORTS
  • 2016-08 Sarcoplasmic reticulum Ca2+ ATPase 2 (SERCA2) reduces the migratory capacity of CCL21-treated monocyte-derived dendritic cells in EXPERIMENTAL & MOLECULAR MEDICINE
  • 2016-03 Transplant outcomes of the triple-negative NPM1/FLT3-ITD/CEBPA mutation subgroup are equivalent to those of the favourable ELN risk group, but significantly better than the intermediate-I risk group after allogeneic transplant in normal-karyotype AML in ANNALS OF HEMATOLOGY
  • 2016-02 Clonal dynamics in a single AML case tracked for 9 years reveals the complexity of leukemia progression in LEUKEMIA
  • 2016-01 Normal karyotype acute myeloid leukemia patients with CEBPA double mutation have a favorable prognosis but no survival benefit from allogeneic stem cell transplant in ANNALS OF HEMATOLOGY
  • 2013-08 Escalated daunorubicin dosing as an induction treatment for Philadelphia-negative adult acute lymphoblastic leukemia in ANNALS OF HEMATOLOGY
  • 2013-06 IL10 and TNF variants and risk of non-Hodgkin lymphoma among three Asian populations in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2013-06 Comparison of outcomes between autologous and allogeneic hematopoietic stem cell transplantation for peripheral T-cell lymphomas with central review of pathology in LEUKEMIA
  • 2012-07 A comparison of bortezomib, cyclophosphamide, and dexamethasone (Vel-CD) chemotherapy without and with thalidomide (Vel-CTD) for the treatment of relapsed or refractory multiple myeloma in ANNALS OF HEMATOLOGY
  • 2011-12 Allogeneic stem cell transplantation in patients with non-Hodgkin lymphoma who experienced relapse or progression after autologous stem cell transplantation in ANNALS OF HEMATOLOGY
  • 2011-07 Type I and II interferons enhance dendritic cell maturation and migration capacity by regulating CD38 and CD74 that have synergistic effects with TLR agonists in CELLULAR & MOLECULAR IMMUNOLOGY
  • 2010-12 Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) study in BMC CANCER
  • 2010-10 Triterpene esters from Uncaria rhynchophylla drive potent IL-12-dependent Th1 polarization in JOURNAL OF NATURAL MEDICINES
  • 2010-10 Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onset in BONE MARROW TRANSPLANTATION
  • 2010-09 Bortezomib, doxorubicin, and dexamethasone combination therapy followed by thalidomide and dexamethasone consolidation as a salvage treatment for relapsed or refractory multiple myeloma: analysis of efficacy and safety in ANNALS OF HEMATOLOGY
  • 2010-07 Multiple myeloma in Korea: past, present, and future perspectives. Experience of the Korean Multiple Myeloma Working Party in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2010-05 Clinical efficacy of a bortezomib, cyclophosphamide, thalidomide, and dexamethasone (Vel-CTD) regimen in patients with relapsed or refractory multiple myeloma: a phase II study in ANNALS OF HEMATOLOGY
  • 2010 Enhancement of antitumor effect using dendritic cells activated with natural killer cells in the presence of Toll-like receptor agonist in EXPERIMENTAL & MOLECULAR MEDICINE
  • 2009-07 Polymyositis and myocarditis after donor lymphocyte infusion in INTERNATIONAL JOURNAL OF HEMATOLOGY
  • 2009-05 The combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin’s lymphoma in ANNALS OF HEMATOLOGY
  • 2007-11 Multicenter study of intravenous busulfan, cyclophosphamide, and etoposide (i.v. Bu/Cy/E) as conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin's lymphoma in BONE MARROW TRANSPLANTATION
  • 2006-04 Improved therapeutic outcomes of DLBCL after introduction of rituximab in Korean patients in ANNALS OF HEMATOLOGY
  • 2005-03 Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation in BONE MARROW TRANSPLANTATION
  • 2003-11 Constitution and telomere dynamics of bone marrow stromal cells in patients undergoing allogeneic bone marrow transplantation in BONE MARROW TRANSPLANTATION
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

        "@context": "", 
        "affiliation": [
            "affiliation": {
              "id": "", 
              "type": "Organization"
            "isCurrent": true, 
            "type": "OrganizationRole"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
            "id": "", 
            "type": "Organization"
        "familyName": "Lee", 
        "givenName": "Je Jung", 
        "id": "sg:person.01204441075.42", 
        "sameAs": [
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T15:08", 
        "sdLicense": "", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_830.json", 
        "type": "Person"

    Download the RDF metadata as:  json-ld nt turtle xml License info


    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' ''

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' ''

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' ''

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' ''


    This table displays all metadata directly associated to this object as RDF triples.

    28 TRIPLES      10 PREDICATES      17 URIs      7 LITERALS      2 BLANK NODES

    Subject Predicate Object
    1 sg:person.01204441075.42 schema:affiliation N3d3b969a82ec46aeacc4f488dd5594bb
    8 schema:familyName Lee
    9 schema:givenName Je Jung
    10 schema:sameAs
    11 schema:sdDatePublished 2019-03-07T15:08
    12 schema:sdLicense
    13 schema:sdPublisher N053cb0e276ab4d2881669db4eeb12896
    14 sgo:license sg:explorer/license/
    15 sgo:sdDataset persons
    16 rdf:type schema:Person
    17 N053cb0e276ab4d2881669db4eeb12896 schema:name Springer Nature - SN SciGraph project
    18 rdf:type schema:Organization
    19 N3d3b969a82ec46aeacc4f488dd5594bb schema:affiliation
    20 sgo:isCurrent true
    21 rdf:type schema:OrganizationRole
    22 schema:Organization
    23 schema:Organization
    24 schema:Organization
    25 schema:Organization
    26 schema:Organization
    27 schema:Organization
    28 schema:Organization

    Preview window. Press ESC to close (or click here)